首页> 外文期刊>Women’s health. >Development of pulmonary arterial hypertension in women: interplay of sex hormones and pulmonary vascular disease.
【24h】

Development of pulmonary arterial hypertension in women: interplay of sex hormones and pulmonary vascular disease.

机译:女性肺动脉高压的发展:性激素与肺血管疾病的相互作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Pulmonary arterial hypertension (PAH) is a progressive disease of the pulmonary vasculature, ultimately resulting in right heart failure and death. This disease is strongly predominant in females, although little is known regarding how sex influences disease development. Recent developments highlighting the importance of estrogen metabolites in both animal models and human disease have substantially increased our understanding of PAH in women. This review will focus on general knowledge of PAH, translational and basic science data regarding sex hormones in the pulmonary vasculature and on clinical issues that are particular to women with PAH. Future directions for study include the influence of sex hormones on right ventricular responses, improving the understanding of the influence of estrogen exposure in human disease and the study of dehydroepiandrosterone in basic science and human disease.
机译:肺动脉高压(PAH)是一种渐进性的肺血管疾病,最终导致右心衰竭和死亡。尽管性别对疾病发展的影响知之甚少,但这种疾病在女性中占主导地位。最近的发展突显了雌激素代谢物在动物模型和人类疾病中的重要性,极大地增加了我们对女性中PAH的了解。这篇综述将侧重于PAH的常识,有关肺血管中性激素的翻译和基础科学数据,以及PAH女性特有的临床问题。未来的研究方向包括性激素对右心室反应的影响,增进对雌激素暴露对人类疾病影响的理解以及对脱氢表雄酮在基础科学和人类疾病中的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号